Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1951 1
1954 1
1963 1
1971 1
1972 2
1976 1
1977 1
1981 2
1982 3
1983 3
1984 3
1985 2
1986 4
1987 1
1988 1
1989 2
1990 2
1992 2
1994 2
1995 4
1996 3
1997 2
1998 3
1999 6
2000 4
2001 6
2002 8
2003 8
2004 11
2005 9
2006 5
2007 8
2008 10
2009 15
2010 9
2011 8
2012 17
2013 20
2014 22
2015 25
2016 28
2017 24
2018 29
2019 35
2020 18
2021 14
2022 30
2023 22
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

396 results

Results by year

Filters applied: . Clear all
Page 1
Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC, Valk GD. Pieterman CRC, et al. Clin Endocrinol (Oxf). 2022 Oct;97(4):409-423. doi: 10.1111/cen.14727. Epub 2022 Apr 1. Clin Endocrinol (Oxf). 2022. PMID: 35319130 Free PMC article. Review.
Thymus NETs remain one of the most aggressive MEN1-related tumours. Lung NETs are more frequent than previously thought, generally indolent, but rare aggressive cases do occur. Pituitary adenomas are most often prolactinomas and nonfunctioning microadenomas with an …
Thymus NETs remain one of the most aggressive MEN1-related tumours. Lung NETs are more frequent than previously thought, generally in …
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, Maskell NA, Psallidas I. Bibby AC, et al. Eur Respir Rev. 2016 Dec;25(142):472-486. doi: 10.1183/16000617.0063-2016. Eur Respir Rev. 2016. PMID: 27903668 Free PMC article. Review.
Treatment options are summarised, including the importance of palliative care and methods of controlling pleural effusions. The evidence for chemotherapy, radiotherapy and surgery is reviewed, both in the palliative setting and in the context of trimodality treatment. An a …
Treatment options are summarised, including the importance of palliative care and methods of controlling pleural effusions. The evide …
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D, Galateau-Salle F, Greillier L, Hoda MA, Klepetko W, Lacourt A, McElnay P, Maskell NA, Mutti L, Pairon JC, Van Schil P, van Meerbeeck JP, Waller D, Weder W, Cardillo G, Putora PM. Scherpereel A, et al. Eur Respir J. 2020 Jun 11;55(6):1900953. doi: 10.1183/13993003.00953-2019. Print 2020 Jun. Eur Respir J. 2020. PMID: 32451346 Free article.
Other potential parameters should be recorded at baseline and reported in clinical trials. Treatment: (chemo)therapy has limited efficacy in MPM patients and only selected patients are candidates for radical surgery. New promising targeted therapies, immunotherapies …
Other potential parameters should be recorded at baseline and reported in clinical trials. Treatment: (chemo)therapy has limited effi …
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
Husain AN, Colby TV, Ordóñez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Sallé F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR. Husain AN, et al. Arch Pathol Lab Med. 2018 Jan;142(1):89-108. doi: 10.5858/arpa.2017-0124-RA. Epub 2017 Jul 7. Arch Pathol Lab Med. 2018. PMID: 28686500 Free article.
CONCLUSIONS: - There was discussion and consensus opinion regarding guidelines for (1) distinguishing benign from malignant mesothelial proliferations (both epithelioid and spindle cell lesions), (2) cytologic diagnosis of MM, (3) recognition of the key histologic features of ple …
CONCLUSIONS: - There was discussion and consensus opinion regarding guidelines for (1) distinguishing benign from malignant mesothelial prol …
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.
Wang Q, Xu C, Wang W, Zhang Y, Li Z, Song Z, Wang J, Yu J, Liu J, Zhang S, Cai X, Li W, Zhan P, Liu H, Lv T, Miao L, Min L, Li J, Liu B, Yuan J, Jiang Z, Lin G, Chen X, Pu X, Rao C, Lv D, Yu Z, Li X, Tang C, Zhou C, Zhang J, Guo H, Chu Q, Meng R, Liu X, Wu J, Hu X, Zhou J, Zhu Z, Chen X, Pan W, Pang F, Zhang W, Jian Q, Wang K, Wang L, Zhu Y, Yang G, Lin X, Cai J, Feng H, Wang L, Du Y, Yao W, Shi X, Niu X, Yuan D, Yao Y, Huang J, Wang X, Zhang Y, Sun P, Wang H, Ye M, Wang D, Wang Z, Hao Y, Wang Z, Wan B, Lv D, Yu J, Kang J, Zhang J, Zhang C, Wu L, Shi L, Ye L, Wang G, Wang Y, Gao F, Huang J, Wang G, Wei J, Huang L, Li B, Zhang Z, Li Z, Liu Y, Li Y, Liu Z, Yang N, Wu L, Wang Q, Huang W, Hong Z, Wang G, Qu F, Fang M, Fang Y, Zhu X, Du K, Ji J, Shen Y, Chen J, Zhang Y, Ma S, Lu Y, Song Y, Liu A, Zhong W, Fang W. Wang Q, et al. Thorac Cancer. 2023 Sep;14(26):2715-2731. doi: 10.1111/1759-7714.15022. Epub 2023 Jul 17. Thorac Cancer. 2023. PMID: 37461124 Free PMC article.
The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient survival. The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperat …
The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been …
Sellar Metastases: Diagnosis and Management.
Shahein M, Albonette-Felicio T, Carrau RL, Prevedello DM. Shahein M, et al. Neurosurg Clin N Am. 2020 Oct;31(4):651-658. doi: 10.1016/j.nec.2020.06.012. Epub 2020 Aug 14. Neurosurg Clin N Am. 2020. PMID: 32921359 Review.
Differentiating these lesions from other more common lesions such as pituitary adenoma maybe difficult. Management is mainly aimed at the primary lesion and is palliative to improve quality of life or for pathologic confirmation....
Differentiating these lesions from other more common lesions such as pituitary adenoma maybe difficult. Management is mainly aimed at …
New Markers for Management of Mesothelioma.
Nash A, Firth Née Phan T, Creaney J. Nash A, et al. Semin Respir Crit Care Med. 2023 Aug;44(4):491-501. doi: 10.1055/s-0043-1769097. Epub 2023 May 30. Semin Respir Crit Care Med. 2023. PMID: 37253383 Review.
Validation of this result could have important clinical implications. Clinical trials aimed at targeting therapy based on biomarker expression are generally in the early phase setting, with overall results being moderate. ...
Validation of this result could have important clinical implications. Clinical trials aimed at targeting therapy based on biomarker e …
Updates in the diagnosis and treatment of malignant pleural mesothelioma.
Katzman D, Sterman DH. Katzman D, et al. Curr Opin Pulm Med. 2018 Jul;24(4):319-326. doi: 10.1097/MCP.0000000000000489. Curr Opin Pulm Med. 2018. PMID: 29553973 Review.
RECENT FINDINGS: Few randomized trials in MPM have demonstrated improved survival with current therapies. A randomized trial of first-line chemotherapy with and without bevacizumab in unresectable MPM is the only randomized trial of a new treatment regimen to demonstrate a …
RECENT FINDINGS: Few randomized trials in MPM have demonstrated improved survival with current therapies. A randomized trial of first …
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors.
Bianchi A, Chiloiro S, Giampietro A, Gaudino S, Calandrelli R, Mazzarella C, Caldarella C, Rigante M, Gessi M, Lauretti L, De Marinis L, Olivi A, Pontecorvi A, Doglietto F. Bianchi A, et al. Front Endocrinol (Lausanne). 2023 May 3;14:1123267. doi: 10.3389/fendo.2023.1123267. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37206441 Free PMC article. Review.
Growth Hormone-secreting adenomas exhibits variable biological behavior and heterogeneous natural history, ranging from small adenomas and mild disease, to invasive and aggressive neoplasms with more severe clinical picture. Patients not cured or controlled after ne …
Growth Hormone-secreting adenomas exhibits variable biological behavior and heterogeneous natural history, ranging from small aden …
Traditional Treatment Approaches and Role of Immunotherapy in Lung Malignancy and Mesothelioma.
Tamanna MT, Egbune C. Tamanna MT, et al. Cancer Treat Res. 2023;185:79-89. doi: 10.1007/978-3-031-27156-4_5. Cancer Treat Res. 2023. PMID: 37306905
A multidisciplinary approach is essentially to manage a cancer patient efficiently. Thoracic malignancies including lung cancers and pleural mesothelioma are accountable for little more than 11.6% of the global cancer burden [4]. ...It is the cancer of the mesothelial tiss …
A multidisciplinary approach is essentially to manage a cancer patient efficiently. Thoracic malignancies including lung cancers and …
396 results